Can-Fite BioPharma Ltd. (CANF)
1.57
-0.05 (-3.09%)
At close: Jan 15, 2025, 1:40 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| PE Ratio | -1.24 | -1.63 | -2.08 | -1.5 | -0.71 | -3.67 | -4.82 | -4.86 | -7.06 | -5.09 | -4.72 | -4.02 | -4.23 | -12.37 |
| PS Ratio | 12.78 | 21.18 | 30.67 | 29.07 | 4.57 | 6.31 | 28.38 | 197.81 | 205.57 | n/a | n/a | n/a | 60.39 | 61.05 |
| PB Ratio | 1.52 | 3.84 | 1.82 | 3.65 | 3.80 | 8.00 | 7.85 | 8.67 | 3.28 | 4.79 | 10.38 | -18 | 10.46 | n/a |
| P/FCF Ratio | -1.13 | -1.59 | -2.65 | -1.83 | -0.86 | -5.76 | -2.52 | -3.75 | -7.21 | -4.23 | -4.56 | -5.14 | -5.13 | -12.35 |
| P/OCF Ratio | -1.13 | -1.59 | -2.65 | -1.84 | -0.86 | -5.8 | -2.52 | -3.76 | -7.28 | -4.24 | -4.57 | -5.15 | -5.15 | -12.45 |
| OCF/S Ratio | -11.36 | -13.33 | -11.56 | -15.81 | -5.33 | -1.09 | -11.27 | -52.67 | -28.24 | n/a | n/a | n/a | -11.72 | -4.9 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 4.90 | 3.68 | 7.37 | 7.48 | 2.40 | 3.81 | 5.66 | 4.04 | 10.21 | 6.84 | 3.37 | 0.69 | 3.57 | n/a |
| Current Ratio | 4.90 | 3.66 | 7.35 | 7.41 | 2.18 | 2.53 | 3.82 | 4.04 | 9.86 | 6.84 | 3.08 | 0.69 | 3.57 | n/a |
| Asset Turnover | 0.07 | 0.09 | 0.04 | 0.08 | 0.25 | 0.48 | 0.11 | 0.02 | 0.01 | n/a | n/a | n/a | 0.10 | n/a |
| Interest Coverage | -585.36 | -131.12 | -713.44 | -38.95 | -28.12 | -4.5 | -6.71 | -316.3 | -11.37 | -478.88 | -559.16 | -829.26 | -12.65 | -513.62 |
| Return on Equity (ROE) | -1.22 | -2.36 | -0.88 | -2.44 | -5.34 | -2.18 | -1.63 | -1.78 | -0.47 | -0.94 | -2.2 | 4.48 | -2.47 | n/a |
| Return on Assets (ROA) | -0.76 | -1.13 | -0.62 | -1.55 | -1.6 | -0.83 | -0.63 | -0.68 | -0.27 | -0.6 | -1.26 | -3.41 | -1.37 | n/a |
| Return on Capital (ROIC) | -1.03 | -1.49 | -0.73 | -1.71 | -2.45 | -1.12 | -1.22 | -1.13 | -0.41 | -0.82 | -2 | 8.69 | -1.35 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | n/a | n/a | n/a | 100.00% | 100.00% |
| Net Profit Margin | -1.03K% | -1.30K% | -1.48K% | -1.94K% | -642.32% | -172.02% | -588.18% | -4.07K% | -2.91K% | n/a | n/a | n/a | -1.43K% | -493.5% |
| Pretax Profit Margin | -1.03K% | -1.26K% | -1.48K% | -1.89K% | -621.31% | -171.91% | -586.07% | -4.13K% | -3.07K% | n/a | n/a | n/a | -1.58K% | -484.61% |
| Operating Profit Margin | -1.10K% | -1.25K% | -1.51K% | -1.85K% | -590.9% | -141.73% | -873.13% | -5.09K% | -3.89K% | n/a | n/a | n/a | -1.02K% | -505.07% |
| FCF Margin | -1.14K% | -1.33K% | -1.16K% | -1.58K% | -533.32% | -109.63% | -1.13K% | -5.27K% | -2.85K% | n/a | -484.2% | n/a | -1.18K% | -494.48% |
| EBITDA Margin | -1.10K% | -1.24K% | -1.50K% | -1.85K% | -590.21% | -171.07% | -752.53% | -5.12K% | -3.06K% | n/a | -477.2% | n/a | -1.67K% | -450.65% |